Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial.
Riccardo Lencioni
Consultant or Advisory Role - Bayer; Onyx
Honoraria - Bayer
Research Funding - Bayer
Josep M. Llovet
Consultant or Advisory Role - Bayer; Onyx
Honoraria - Bayer
Research Funding - Bayer
Guohong Han
No relevant relationships to disclose
Won-Young Tak
No relevant relationships to disclose
Jiamei Yang
No relevant relationships to disclose
Marie-Aude Leberre
Employment or Leadership Position - Bayer
Woody Niu
Employment or Leadership Position - Bayer
Kate Nicholson
Employment or Leadership Position - Bayer
Gerold Meinhardt
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Jordi Bruix
Consultant or Advisory Role - ArQule; Bayer; Biocompatibles International; Bristol-Myers Squibb; GlaxoSmithKline; Kowa ; Novartis
Honoraria - Bayer
Research Funding - Bayer